Full-Time

Scientist 3

Analytical R&D

Updated on 9/4/2026

Granules

Granules

501-1,000 employees

Vertically integrated API and dosage manufacturer

Compensation Overview

$85k - $95k/yr

Chantilly, VA, USA

In Person

Master's, PhD

Category
Biology & Biotech (1)
Required Skills
GMP

Get referred to Granules

See people who can refer or advise you

Requirements
  • Plan and execute method development, method validation, and technology transfer activities for active pharmaceutical ingredients, excipients, package components, and finished products.
  • Prepare and review standard operating procedures, protocols, and reports to support laboratory good manufacturing practice compliance with Food and Drug Administration, International Council for Harmonisation, and other regulatory guidance.
  • Plan, review, and implement additional studies such as cleaning validation, photostability, in-use studies, multimedia dissolution, and shipping studies.
  • Plan and design experiments to address chemistry, manufacturing, and controls deficiencies responses.
  • Perform out-of-trend, out-of-specification, and laboratory-deviation investigations according to standard operating procedures.
  • Meet all company-required and regulatory training requirements.
  • Provide regular, timely reports, interpret analytical data, and present results to the Analytical Research and Development manager and head as needed.
  • Have knowledge of active pharmaceutical ingredients, excipients, and finished products in generic pharmaceuticals.
  • Have hands-on experience with analytical techniques including high-performance liquid chromatography, gas chromatography, Karl Fischer, mass spectrometry, dissolution, spectroscopy, and particle-size analysis.
  • Have a functional understanding of small-molecule analytical development and associated regulatory and quality requirements.
  • Have an in-depth understanding of good manufacturing practices and applicable chemistry, manufacturing, and controls, analytical, and manufacturing regulatory guidance.
  • Have a Master's degree in Analytical Chemistry or Chemistry, or a related field, with at least five years of experience, or a PhD with at least three years of experience.
  • Have experience in small-molecule solid-oral-dosage analytical development.
  • Be able to stand for long periods, including up to 12-hour shifts, maneuver at least 40 pounds, wear a respirator, pass associated respirator tests and requirements, and wear required personal protective equipment.
  • Be able to see details at close range.
Responsibilities
  • Oversee analytical techniques, interpretation of analytical data, problem-solving, and troubleshooting for Analytical Research and Development activities.
  • Prepare and review standard operating procedures, protocols, and reports to support laboratory good manufacturing practice compliance.
  • Manage the Analytical Research and Development function in the laboratory to ensure current good manufacturing practice compliance.
  • Review staff performance regularly and develop team members to enhance individual and overall team performance.
  • Identify training needs and develop direct and indirect reports for future opportunities.

Granules India makes APIs, PFIs, and finished dosages, using large-scale, vertically integrated plants that control production from base chemicals to final medicines. Its products include common off-patent APIs like Paracetamol, Ibuprofen, Metformin, and Guaifenesin, and it is expanding into more complex areas such as MUPS, oncology, and peptide therapies with US FDA approvals. The company differentiates itself through full vertical integration, large scale, and a global manufacturing footprint that supports both contract manufacturing and its own branded products, offering supply security and cost competitiveness. Its goal is to deliver reliable, affordable medicines to customers worldwide while growing capabilities in complex therapies and pursuing sustainable practices like green chemistry.

Company Size

501-1,000

Company Stage

N/A

Total Funding

N/A

Headquarters

N/A

Founded

2014

Get referred to Granules

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q3 FY26 revenue rose 22% to INR 1,388 crores, led by North America and Europe.
  • July 2026 inspections at Genome Valley and Chantilly improved regulatory optionality and capacity.
  • Europe grew 151% year-on-year in FY26, while peptide CDMO opened a new revenue vertical.

What critics are saying

  • FDA warning letter dated February 26, 2025 threatens Gagillapur product approvals until remediation closes.
  • Reuters on April 9, 2026 reported record-keeping and contamination concerns still burden management.
  • Any second FDA action at Gagillapur can shut U.S. launches and damage Granules' generics franchise.

What makes Granules unique

  • Granules integrates APIs, PFIs, and dosages, preserving cost control across the value chain.
  • February 2025 Senn Chemicals acquisition adds peptide CDMO capabilities and European regulated-market access.
  • Granules shipped in 80 countries and won 94 approvals by August 2026.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours